Table 2. Genetic differentiation (FST) among major continental groups and HapMap 2 populations in comparison to other data sets.
| Gene sets or SNP data sets |
Among HapMap 2 populations |
Among regions | ||
|---|---|---|---|---|
| YRI vs CEU | YRI vs CHB+JPT | CEU vs CHB+JPT | ||
| Telomere biology genes (37 genes, 716 SNPs, N=1168)b | 0.136 | 0.189 | 0.095 | 0.095a |
| Shelterin genes | 0.140 | 0.224 | 0.148 | 0.109 |
| Telomerase complex genes | 0.130 | 0.161 | 0.071 | 0.072 |
| DNA repair genes | 0.154 | 0.209 | 0.099 | 0.107 |
| Helicase genes | 0.139 | 0.196 | 0.071 | 0.085 |
| Other telomere-associated genes | 0.098 | 0.144 | 0.093 | 0.086 |
| CVD genes (364 genes, 15 559 SNPs, N=270)c | 0.139 | 0.158 | 0.095 | — |
| Blood circulation and gas exchange genes | 0.129 | 0.158 | 0.062 | — |
| Lipoprotein metabolism genes | 0.144 | 0.165 | 0.082 | — |
| Insulin/IGF-mitogen-activated protein kinase kinase/ MAP kinase cascade genes | 0.194 | 0.174 | 0.138 | — |
| Disease associated SNPs (25 SNPs, N=952)d | — | — | — | 0.10a |
| Innate immune genes (174 genes, 1396 SNPs, N=917) | — | — | — | 0.11 |
| Genome-wide autosomal SNP averagee | — | — | — | 0.10–0.15 |
Abbreviations: CEU, Utah; CHB, Han; CVD, cardiovascular disease; IGF, insulin-like growth factor; JPT, Japanese; MAP, mitogen-activated protein kinase; N=number of individuals; SNP, single-nucleotide polymorphism; YRI, Yoruba.
Among the seven geographic regions represented in the CEPH-HGDP panel.
See methods for a description of genes included in each gene set.